C12Y 203/01024
Sphingosine n-acyltransferase
Official title: Sphingosine N-acyltransferase (2.3.1.24)
C12Y203/01024 (Sphingosine n-acyltransferase) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 4
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 26 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for diagnosing, treating, and preventing lysosomal storage diseases24 Sep 2026US 2026/0286363 A1Wylder Nation Foundation
- Treatment and prevention of aging related-disease and/or aging by the inhibition of sphingolipids15 Sep 2022US 2022/0288004 A1Ecole Polytechnique Federale De Lausanne (Epfl)
- Methods of inhibiting fungal ceramide synthase for treatment of cryptococcus neoformans infection4 Jun 2020US 2020/0171132 A1The Research Foundation for The State University of New York
- Method for producing sphingoid base or sphingolipid28 Jun 2018US 2018/0179563 A1Ajinomoto Co., Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.